Key Client Fiduciary Advisors’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$975K Buy
7,589
+186
+3% +$21.8K 0.28% 75
2026
Q1
$891K Buy
7,403
+530
+8% +$61.2K 0.3% 71
2025
Q4
$724K Sell
6,873
-306
-4% -$28.7K 0.25% 84
2025
Q3
$603K Sell
7,179
-22
-0.3% -$1.81K 0.2% 99
2025
Q2
$570K Sell
7,201
-767
-10% -$61K 0.23% 99
2025
Q1
$715K Buy
7,968
+26
+0.3% +$2.43K 0.33% 68
2024
Q4
$790K Sell
7,942
-714
-8% -$73.6K 0.35% 67
2024
Q3
$983K Sell
8,656
-39
-0.4% -$4.63K 0.44% 55
2024
Q2
$1.08M Sell
8,695
-3
-0% -$386 0.53% 47
2024
Q1
$1.15M Buy
8,698
+2,135
+33% +$263K 0.61% 36
2023
Q4
$716K Buy
6,563
+606
+10% +$62.9K 0.42% 53
2023
Q3
$613K Buy
5,957
+218
+4% +$23.5K 0.38% 63
2023
Q2
$662K Sell
5,739
-105
-2% -$11.9K 0.39% 56
2023
Q1
$622K Sell
5,844
-129
-2% -$13.9K 0.39% 59
2022
Q4
$663K Buy
5,973
+2,328
+64% +$238K 0.45% 53
2022
Q3
$314K Hold
3,645
0.28% 76
2022
Q2
$332K Sell
3,645
-12
-0.3% -$1.06K 0.32% 72
2022
Q1
$300K Buy
3,657
+7
+0.2% +$552 0.24% 98
2021
Q4
$280K Buy
+3,650
New +$291K 0.23% 100

Other funds holding MRK

Key Client Fiduciary Advisors's MRK Position: Q2 2026 in Review

Key Client Fiduciary Advisors increased its Merck (MRK) stake by 2.5% in Q2 2026, buying an estimated $21.8K and bringing the position to 7,589 shares worth $975K. The position accounts for 0.28% of the portfolio, ranked #75.

Key Client Fiduciary Advisors first reported a position in MRK in Q4 2021 and has held it in 19 quarters since. The position peaked at $1.15M in Q1 2024. 1,867 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Key Client Fiduciary Advisors held 7,589 shares of Merck worth $975K as of Q2 2026.
  • Key Client Fiduciary Advisors bought 186 Merck shares in Q2 2026, an estimated $21.8K.
  • Merck made up 0.28% of Key Client Fiduciary Advisors's portfolio in Q2 2026, its #75 holding.
  • Key Client Fiduciary Advisors first reported a position in Merck in Q4 2021 and has held it in 19 quarters since.
  • Key Client Fiduciary Advisors's Merck position peaked at $1.15M in Q1 2024.
  • 1,867 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Key Client Fiduciary Advisors's 13F filing for Q2 2026, filed 9 Jul 2026.